Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.

Horizontal portrait of David Beard

An Honorary Fellowship is the highest honour that the BOA (British Orthopaedic Association) can confer. It was awarded to Professor Beard in recognition of his outstanding contribution and achievements in research across the Trauma and Orthopaedic spectrum leading to improvements in patient care.

Professor Beard is one of the nominated Royal College of Surgeons (Eng) Surgical Trials chairs and Rosetrees Director of the Surgical Intervention Trials Unit (SITU-NDORMS) being responsible for a portfolio of surgical and complex intervention trials, many as co-applicant and some as Chief Investigator.

He is currently researching the introduction of robotic surgery in the NHS, surgical clinical trials methodology, including placebo control designs, and a host of musculoskeletal intervention efficacy studies. He is also involved in several international surgical trials and and supervises postgraduate students within NDORMS.

On being awarded the Honorary Fellowship, Professor Beard said;  

“I am very privileged and honoured to be given such a prestigious Fellowship by the BOA, especially in my core discipline, orthopaedic science. Like most personal awards the letters and certificate may point to a single name but it simply would not happen without the support and help from a set of first rate colleagues both in the Department and around the country.  To me it is very much a shared team award reflecting and recognising the success of orthopaedic/MSK research in Oxford (and the UK) over many years. Similar to everyone in NDORMS, I shall continue to do my very best research under the overall umbrella of improving healthcare, but it would give added satisfaction to see NDORMS remaining in the very top flight of those pursuing such an endeavour.” 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.